Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
11
currently held
Exits tracked
3
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin13 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Omnicare2 periods Equistone Partners Europe Fund VI | Equistone Partners Europe | 2019 | 7yr | Exited 2026 | Allianz ambulante Onkologie | – | |||
Pharmaceutical Product Development, Inc. (PPD) Carlyle Partners V, L.P. | The Carlyle Group | – | – | Exited 2021 | Thermo Fisher Scientific | – | |||
Simtra BioPharma Solutions2 periods Latin American Private Equity Fund VII | Advent International | – | – | Active | – | – | |||
Abacus Pharmaceuticals Carlyle Sub-Saharan Africa Fund | The Carlyle Group | – | – | Active | – | – | |||
Advantice Health TA XIV | TA Associates | – | – | Active | – | – | |||
Alcami Corporation GHO Capital III LP | GHO Capital | 2022 | 4yr | Active | – | – | |||
Anovo Ardian Co-Investment Fund VI | Ardian | – | – | Active | – | – | |||
BioDuro Latin American Private Equity Fund VII | Advent International | – | – | Active | – | – | |||
Cambrex Permira VII | Permira | 2019 | 7yr | Active | – | – | |||
curia The Carlyle Group Portfolio | The Carlyle Group | – | – | Active | – | – | |||
OcuMension General Atlantic Portfolio | General Atlantic | – | – | Active | – | – | |||
Pharmscript Summit Partners Portfolio | Summit Partners | – | – | Active | – | – | |||
PharMEDium Healthcare Corporation CD&R Other Investments | CD&R | – | – | Active | – | – |
Omnicare
Equistone Partners Europe Fund VI
USASector
Pharma
InvestorEquistone Partners Europe
Entry
2019
Hold
7yr
Owners
2
Exit
2026
to Allianz ambulante Onkologie
Pharmaceutical Product Development, Inc. (PPD)
Carlyle Partners V, L.P.
USASector
Pharma
InvestorThe Carlyle Group
Entry
–
Exit
2021
to Thermo Fisher Scientific
Simtra BioPharma Solutions
Latin American Private Equity Fund VII
USASector
Pharma
InvestorAdvent International
Entry
–
Owners
2
Abacus Pharmaceuticals
Carlyle Sub-Saharan Africa Fund
USASector
Pharma
InvestorThe Carlyle Group
Entry
–
Advantice Health
TA XIV
USASector
Pharma
InvestorTA Associates
Entry
–
Alcami Corporation
GHO Capital III LP
USASector
Pharma
InvestorGHO Capital
Entry
2022
Hold
4yr
Anovo
Ardian Co-Investment Fund VI
USASector
Pharma
InvestorArdian
Entry
–
BioDuro
Latin American Private Equity Fund VII
USASector
Pharma
InvestorAdvent International
Entry
–
Cambrex
Permira VII
USASector
Pharma
InvestorPermira
Entry
2019
Hold
7yr
curia
The Carlyle Group Portfolio
USASector
Pharma
InvestorThe Carlyle Group
Entry
–
OcuMension
General Atlantic Portfolio
USASector
Pharma
InvestorGeneral Atlantic
Entry
–
Pharmscript
Summit Partners Portfolio
USASector
Pharma
InvestorSummit Partners
Entry
–
PharMEDium Healthcare Corporation
CD&R Other Investments
USASector
Pharma
InvestorCD&R
Entry
–